Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Genmab (NASDAQ:GMAB) through any online brokerage.
Other companies in Genmab’s space includes: BeOne Medicines Ltd (NASDAQ:ONC), Neurocrine Biosciences Inc (NASDAQ:NBIX), Ionis Pharmaceuticals Inc (NASDAQ:IONS), Roivant Sciences Ltd (NASDAQ:ROIV) and Amgen Inc (NASDAQ:AMGN).
Genmab has a consensus price target of $38.73.
The stock price for Genmab (NASDAQ: GMAB) is $25.83 last updated March 30, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Genmab.
Genmab does not have any upcoming earnings scheduled.
There is no upcoming split for Genmab.
Genmab is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.